<DOC>
	<DOCNO>NCT01992211</DOCNO>
	<brief_summary>The purpose study evaluate pharmacokinetic Profile Safety/Tolerability BCWP_C003 compare Co-Administration Crestor 10mg Glucophage XR 1000mg , evaluate food effect Pharmacokinetic profile BCWP_C003 administration .</brief_summary>
	<brief_title>Evaluating Pharmacokinetic Profile BCWP_C003 Co-administration Rosuvastatin Metformin</brief_title>
	<detailed_description>Clinical Trials Evaluate Pharmacokinetic Profiles Safety/Tolerability BCWP_C003 Formulation compare Coadministration Rosuvastatin Metformin SR Formulation , Evaluate Effect Food Pharmacokinetic Profile BCWP_C003 Single Oral Administration Healthy Male Subjects .</detailed_description>
	<mesh_term>Metformin</mesh_term>
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Healthy Male Volunteer , age 19 45 year time screen Body weight less 55kg , 90kg result Body Mass Index ( BMI ) less 18.5 , 25.0 Subject congenital , chronic disease , disease symptom find medical examination result Subject comprehend purpose , content study , property clinical drug sign inform consent participate trial willingness Subject history hypersensitivity reaction relevant drug ( statin , biguanide ) clinically significant hypersensitivity reaction Subject history presence clinically disease liver , kidney , gastrointestinal tract , respiratory system , musculoskeletal , endocrine system , mental disorder , bloodtumor , cardiovascular . Particulary , subject bleed disorder tend bleed bruise easily Subject family history hereditary muscular disorder muscular side effect Subject history gastrointestinal tract disorder affect drug absorption surgery ( exclude appendectomy , hernia surgery ) Subject take diagnosis peptic ulcer within 2 month prior drug administration Subject result clinical laboratory test follow : AST , ALT level exceed normal range 1.5 time Total bilirubin level exceed normal range 1.5 time Creatinine clearance 60mL/min calculate MDRD In vital sign , systolic blood pressure 150mmHg , less 90mmHg diastolic blood pressure 95mmHg , less 50mmHg Subject presence history drug abuse , positive screen drug abuse â†’ Alcohol abuse defines drink 21 unit/week ( alcohol 1unit = 10g = 12.5 mL ) persistingly Subject participate another clinical trial within 3 month prior drug administration Subject take medicine ( Barbital etc ) relate drug metabolize enzyme induction inhibition within 1 month prior drug administration Subject take prescription drug oriental medicine within 2 week OTC drug vitamin formulation within week prior drug administration Subject diet affect absorption , distribution , metabolism elimination Rosuvastatin/Metformin ( Particulary , Grapefruit within 48h prior drug administration ) Subject donate whole blood within 2 month component blood within 1 month prior drug administration Subject smoke 10 cigarette per day Subject positive HBsAg , HCV Ab HIV Ab Subject judge ineligible principal investigator subinvestigator accord various test result</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>